137 related articles for article (PubMed ID: 19836380)
1. Cadherins as novel targets for anti-cancer therapy.
Blaschuk OW; Devemy E
Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
[TBL] [Abstract][Full Text] [Related]
2. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion.
Burden-Gulley SM; Gates TJ; Craig SE; Lou SF; Oblander SA; Howell S; Gupta M; Brady-Kalnay SM
Peptides; 2009 Dec; 30(12):2380-7. PubMed ID: 19765627
[TBL] [Abstract][Full Text] [Related]
3. Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization.
Kelland L
Curr Opin Mol Ther; 2007 Feb; 9(1):86-91. PubMed ID: 17330406
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin as an invasion promoter: a novel target for antitumor therapy?
Cavallaro U
Curr Opin Investig Drugs; 2004 Dec; 5(12):1274-8. PubMed ID: 15648948
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel N-cadherin antagonist.
Devemy E; Blaschuk OW
Peptides; 2008 Nov; 29(11):1853-61. PubMed ID: 18655820
[TBL] [Abstract][Full Text] [Related]
6. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
8. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecules as targets for cancer therapy.
Huang YW; Baluna R; Vitetta ES
Histol Histopathol; 1997 Apr; 12(2):467-77. PubMed ID: 9151136
[TBL] [Abstract][Full Text] [Related]
10. Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis.
Ramis-Conde I; Chaplain MA; Anderson AR; Drasdo D
Phys Biol; 2009 Mar; 6(1):016008. PubMed ID: 19321920
[TBL] [Abstract][Full Text] [Related]
11. Role of cadherins in the transendothelial migration of melanoma cells in culture.
Sandig M; Voura EB; Kalnins VI; Siu CH
Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
[TBL] [Abstract][Full Text] [Related]
12. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
14. Cadherin superfamily of adhesion molecules in primary lung cancer.
Charalabopoulos K; Gogali A; Kostoula OK; Constantopoulos SH
Exp Oncol; 2004 Dec; 26(4):256-60. PubMed ID: 15627055
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin antagonists as oncology therapeutics.
Blaschuk OW
Philos Trans R Soc Lond B Biol Sci; 2015 Feb; 370(1661):20140039. PubMed ID: 25533096
[TBL] [Abstract][Full Text] [Related]
16. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif.
Williams EJ; Williams G; Gour B; Blaschuk O; Doherty P
Mol Cell Neurosci; 2000 May; 15(5):456-64. PubMed ID: 10833302
[TBL] [Abstract][Full Text] [Related]
17. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
18. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling.
Derycke LD; Bracke ME
Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821
[TBL] [Abstract][Full Text] [Related]
19. Integrins, cadherins, and catenins: molecular cross-talk in cancer cells.
Pignatelli M
J Pathol; 1998 Sep; 186(1):1-2. PubMed ID: 9875132
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel dual E- and N-cadherin antagonist.
Devemy E; Blaschuk OW
Peptides; 2009 Aug; 30(8):1539-47. PubMed ID: 19465078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
